Financials Eurofins Scientific SE

Equities

Market Closed - Euronext Paris Other stock markets 11:35:15 2025-01-24 am EST			5-day change	1st Jan Change
48.35 ^EUR	+1.02%		+2.72%	-1.95%

Jan. 24	Eurofins: Barclays downgrades to 'online weighted'.	CF
Jan. 24	EUROFINS : Barclays downgrades to 'online weighted'.	CF

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	4,563	5,439	6,718	6,712	6,515	6,958	7,519	8,062
Change	-	19.2%	23.52%	-0.09%	-2.94%	6.8%	8.06%	7.22%
EBITDA ¹	930.7	1,413	1,902	1,513	1,364	1,512	1,668	1,832
Change	-	51.79%	34.64%	-20.45%	-9.85%	10.85%	10.3%	9.86%
EBIT ¹	573.5	1,024	1,473	1,037	842	919.1	1,043	1,172
Change	-	78.48%	43.9%	-29.6%	-18.8%	9.16%	13.5%	12.33%
Interest Paid ¹	-95.7	-107.7	-204	-137	-107	-123.3	-114.2	-110
Earnings before Tax (EBT) ¹	271.5	694.4	1,057	780	423	570.5	684.2	806.6
Change	-	155.76%	52.16%	-26.18%	-45.77%	34.87%	19.94%	17.89%
Net income ¹	195.2	539.4	783	606	310	412	505.1	606.5
Change	-	176.33%	45.16%	-22.61%	-48.84%	32.91%	22.6%	20.06%
Announcement Date	3/4/20	3/1/21	2/22/22	3/1/23	2/27/24	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2023 Q1	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3
Net sales ¹	1,167	1,228	1,142	1,181	1,413	1,703	1,614	1,658	1,630	1,816	1,760	1,652	1,622	1,574	1,611	1,695	1,653	1,766	1,723
Change	-	5.24%	-7.01%	3.42%	19.64%	20.52%	-5.23%	2.73%	-1.69%	11.41%	-3.08%	-6.14%	-1.85%	-2.93%	2.35%	5.21%	-2.48%	6.84%	-2.43%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	10/28/19	3/4/20	4/28/20	8/6/20	10/22/20	3/1/21	4/28/21	8/5/21	10/21/21	2/22/22	4/21/22	7/27/22	10/18/22	4/26/23	10/24/23	2/27/24	4/24/24	7/24/24	10/22/24

¹EUR in Million

Estimates

Fiscal Period: December	2020 S1	2020 S2	2021 S1	2021 S2	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1	2024 S2	2025 S1	2025 S2
Net sales ¹	2,323	3,116	3,272	3,446	3,412	3,300	3,209	3,306	3,419	3,548	3,643	3,833
Change	-	34.14%	5.01%	5.32%	-0.99%	-3.28%	-2.76%	3.02%	3.42%	3.78%	2.68%	5.21%
EBITDA	493	919.7	1,008	894	829	-	640	-	757	-	-	-
Change	-	86.55%	9.6%	-11.31%	-7.27%	-100%	-	-100%	-	-100%	-	-
EBIT	310.7	-	-	-	-	-	397	-	-	-	-	-
Change	-	-100%	-	-	-	-	-	-100%	-	-	-	-
Charge d'intérêts	-	-	-	-	-	-	-59	-65	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	220	-	-	-	-	-
Change	-	-	-	-	-	-	-	-100%	-	-	-	-
Net income	-	-	-	-	-	-	152	-	-	-	-	-
Change	-	-	-	-	-	-	-	-100%	-	-	-	-
Announcement Date	8/6/20	3/1/21	8/5/21	2/22/22	7/27/22	3/1/23	7/26/23	2/27/24	7/24/24	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	3,245	2,242	2,239	2,839	2,705	2,992	2,945	2,731
Change	-	-30.91%	-0.13%	26.8%	-4.72%	10.61%	-1.57%	-7.27%
Announcement Date	3/4/20	3/1/21	2/22/22	3/1/23	2/27/24	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	420	350.3	495	645	543.6	596.7	624.3	660
Change	-	-16.6%	41.31%	30.3%	-15.72%	9.76%	4.63%	5.71%
Free Cash Flow (FCF) ¹	258	873.2	1,015	677	474.2	602.7	688.1	801.6
Change	-	238.45%	16.24%	-33.3%	-29.96%	27.09%	14.18%	16.48%
Announcement Date	3/4/20	3/1/21	2/22/22	3/1/23	2/27/24	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	20.4%	25.97%	28.31%	22.54%	20.94%	21.73%	22.18%	22.73%
EBIT Margin (%)	12.57%	18.82%	21.93%	15.45%	12.92%	13.21%	13.87%	14.54%
EBT Margin (%)	5.95%	12.77%	15.73%	11.62%	6.49%	8.2%	9.1%	10.01%
Net margin (%)	4.28%	9.92%	11.66%	9.03%	4.76%	5.92%	6.72%	7.52%
FCF margin (%)	5.65%	16.05%	15.11%	10.09%	7.28%	8.66%	9.15%	9.94%
FCF / Net Income (%)	132.17%	161.88%	129.63%	111.72%	152.97%	146.27%	136.23%	132.17%
Profitability
ROA	2.6%	6.58%	8.74%	6.24%	2.96%	3.39%	4.49%	5.48%
ROE	7.09%	16.52%	18.78%	12.85%	6.29%	11.2%	11.16%	11.98%
Financial Health
Leverage (Debt/EBITDA)	3.49x	1.59x	1.18x	1.88x	1.98x	1.98x	1.77x	1.49x
Debt / Free cash flow	12.58x	2.57x	2.21x	4.19x	5.7x	4.96x	4.28x	3.41x
Capital Intensity
CAPEX / Current Assets (%)	9.2%	6.44%	7.37%	9.61%	8.34%	8.58%	8.3%	8.19%
CAPEX / EBITDA (%)	45.13%	24.8%	26.03%	42.63%	39.85%	39.46%	37.43%	36.02%
CAPEX / FCF (%)	162.79%	40.12%	48.77%	95.27%	114.64%	99.01%	90.72%	82.33%
Items per share
Cash flow per share ¹	3.645	6.246	7.512	5.71	5.144	5.61	6.231	7.043
Change	-	71.36%	20.29%	-23.99%	-9.92%	9.07%	11.08%	13.02%
Dividend per Share ¹	0.345	0.68	1	1	0.5	0.6035	0.7206	0.8112
Change	-	97.1%	47.06%	0%	-50%	20.71%	19.4%	12.57%
Book Value Per Share ¹	15.91	19.34	24.21	24.83	26.33	27.32	29.33	32.27
Change	-	21.59%	25.16%	2.56%	6.04%	3.78%	7.35%	10.02%
EPS ¹	1.047	2.75	3.91	3.02	1.3	2.273	2.684	3.205
Change	-	162.66%	42.18%	-22.76%	-56.95%	74.87%	18.08%	19.39%
Nbr of stocks (in thousands)	178,759	190,749	192,035	192,365	192,194	188,049	188,049	188,049
Announcement Date	3/4/20	3/1/21	2/22/22	3/1/23	2/27/24	-	-	-